Skip to main content
. 2021 Jan 21;2:100032. doi: 10.1016/j.hpopen.2021.100032

Table 2.

Types of stakeholders whose views were sought for the implementation of MEAs.

Author/ Year Government/ Public service personnel Manufacturer/ Pharmaceutical organization Health plan manager/ Health insurers Clinicians Pharmacist (Various role) Academics Consumer advocates/ non-governmental organization members Government Advisors/ Experts/ Health technology assessment agency Patients
. Lu CY et al./2007
Jakub Adamski et al./2010
Espin J. etal./2011
Sabine Vogler et al./2012
Lisbet Coulton et al./2012
Ariel Hammerman et al./2012
Paige A. Thomson et al./2012
Steve G. Morgan et al./2013
Louis. P Garrison et al./2015
Melissa Thompson et al./2016
Arvind Mani et al./2016
Taza Nazareth et al./2017
Kim Pauwels et al./2017
Steve G. Morgan et al./2017
Joseph A. Goble et al./2017
Alessandra Ferrario et al./2017
William C.N. Dunlop et al./2018
Christiane Maskineh et al./2018
Jacoline C. Bouvy et al./2018
Alexandru M. Rotar et al./2018